715 related articles for article (PubMed ID: 33641066)
1. Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.
Takahashi A; Yousif A; Hong L; Chefetz I
J Mol Med (Berl); 2021 May; 99(5):637-650. PubMed ID: 33641066
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.
Yang Z; Du X; Wang C; Zhang J; Liu C; Li Y; Jiang H
Stem Cell Res Ther; 2019 Aug; 10(1):250. PubMed ID: 31412919
[TBL] [Abstract][Full Text] [Related]
3. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1.
Huang B; Qian C; Ding C; Meng Q; Zou Q; Li H
Stem Cell Res Ther; 2019 Nov; 10(1):362. PubMed ID: 31783916
[TBL] [Abstract][Full Text] [Related]
4. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Wang Z; Tang D; Luo Y; Xiong Z
Stem Cell Res Ther; 2019 Jan; 10(1):46. PubMed ID: 30683144
[TBL] [Abstract][Full Text] [Related]
5. Effects of Human Amnion-Derived Mesenchymal Stem Cell (hAD-MSC) Transplantation In Situ on Primary Ovarian Insufficiency in SD Rats.
Feng X; Ling L; Zhang W; Liu X; Wang Y; Luo Y; Xiong Z
Reprod Sci; 2020 Jul; 27(7):1502-1512. PubMed ID: 31953773
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner.
Jiao W; Mi X; Yang Y; Liu R; Liu Q; Yan T; Chen ZJ; Qin Y; Zhao S
Stem Cell Res Ther; 2022 Feb; 13(1):49. PubMed ID: 35109928
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) alleviate excessive autophagy of ovarian granular cells through VEGFA/PI3K/AKT/mTOR pathway in premature ovarian failure rat model.
Dai W; Yang H; Xu B; He T; Liu L; Ma X; Ma J; Yang G; Si R; Pei X; Du X; Fu X
J Ovarian Res; 2023 Sep; 16(1):198. PubMed ID: 37777781
[TBL] [Abstract][Full Text] [Related]
8. Human Bone Marrow Derived-Mesenchymal Stem Cells Treatment for Autoimmune Premature Ovarian Insufficiency.
Ma WQ; Zhuo AP; Xiao YL; Gao M; Yang YT; Tang LC; Wu YH; Tian D; Fu XF
Stem Cell Rev Rep; 2024 Feb; 20(2):538-553. PubMed ID: 38049593
[TBL] [Abstract][Full Text] [Related]
9. Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model.
Park HS; Chugh RM; Elsharoud A; Ulin M; Esfandyari S; Aboalsoud A; Bakir L; Al-Hendy A
Cell Transplant; 2021; 30():963689720988502. PubMed ID: 33593078
[TBL] [Abstract][Full Text] [Related]
10. Effects of VEGF
Vural B; Duruksu G; Vural F; Gorguc M; Karaoz E
Stem Cell Rev Rep; 2019 Aug; 15(4):558-573. PubMed ID: 31037585
[TBL] [Abstract][Full Text] [Related]
11. Adipose-Derived Mesenchymal Stem Cell Transplantation in Chemotherapy-Induced Premature Ovarian Insufficiency: the Role of Connexin and Pannexin.
Sen Halicioglu B; Saadat KASM; Tuglu MI
Reprod Sci; 2022 Apr; 29(4):1316-1331. PubMed ID: 34449073
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Zhang W; He L; Wang Z; Zeng Q; Xiong Z
Stem Cell Res Ther; 2017 Dec; 8(1):283. PubMed ID: 29258619
[TBL] [Abstract][Full Text] [Related]
13. The mechanisms of MicroRNA 21 in premature ovarian insufficiency mice with mesenchymal stem cells transplantation : The involved molecular and immunological mechanisms.
Yin N; Luo C; Wei L; Yang G; Bo L; Mao C
J Ovarian Res; 2024 Apr; 17(1):75. PubMed ID: 38575997
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice.
Zhao Y; Ma J; Yi P; Wu J; Zhao F; Tu W; Liu W; Li T; Deng Y; Hao J; Wang H; Yan L
Stem Cell Res Ther; 2020 Nov; 11(1):466. PubMed ID: 33148334
[TBL] [Abstract][Full Text] [Related]
15. HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary.
Chen J; Jia Z; Zhang F; Han C; Zhao L; Jia Y; Cui M
Tissue Cell; 2023 Jun; 82():102121. PubMed ID: 37285749
[TBL] [Abstract][Full Text] [Related]
16. Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy.
Lu G; Li HX; Song ZW; Luo J; Fan YL; Yin YL; Shen J; Shen MH
Stem Cell Res Ther; 2024 Apr; 15(1):102. PubMed ID: 38589967
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Inhibin B in the Chemotherapy Drug-Induced Premature Ovarian Insufficiency Mice and hPMSCs Treatment.
Luo Q; Liu R; Wang L; Hou Y; Zhang H
Reprod Sci; 2020 May; 27(5):1148-1155. PubMed ID: 31993999
[TBL] [Abstract][Full Text] [Related]
18. Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure.
Shi L; Zhang Z; Deng M; Zheng F; Liu W; Ye S
Medicine (Baltimore); 2022 Aug; 101(32):e30013. PubMed ID: 35960112
[TBL] [Abstract][Full Text] [Related]
19. Metformin improves d-galactose induced premature ovarian insufficiency through PI3K-Akt-FOXO3a pathway.
Ellibishy F; Tarek M; Abd-Elsalam MM; Elgayar N; El Bakly W
Adv Med Sci; 2024 Mar; 69(1):70-80. PubMed ID: 38387407
[TBL] [Abstract][Full Text] [Related]
20. Adipose-Derived Mesenchymal Stem Cells: A Promising Tool in the Treatment of pre mature ovarian failure.
Nouri N; Aghebati-Maleki L; Yousefi M
J Reprod Immunol; 2021 Sep; 147():103363. PubMed ID: 34450435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
